10 December 2020>: Clinical Research
Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
Tomasz Siwek 12ABDEFG* , Katarzyna Jezierska-Woźniak 3ABDEF , Stanisław Maksymowicz 4BCDEF , Monika Barczewska 56BD , Mariusz Sowa 56B , Wanda Badowska 7B , Wojciech Maksymowicz 56ADGDOI: 10.12659/MSM.927484
Med Sci Monit 2020; 26:e927484
Figure 1 The monthly decrease in Revised Amyotrophic Lateral Sclerosis Functional Rating Scale scores before and after treatment for all participants (P=0.57).